Trial
NCT03382886
Nivolumab and Bevacizumab in Patients With Advanced and or Metastatic Hepatocellular Carcinoma
Phase ITERMINATEDOPERATIONALConfidence: HIGH
Sponsor
University of Utah
Collaborators
Bristol-Myers Squibb
Condition
Hepatocellular Carcinoma
Intervention
Nivolumab
Why stopped
PI decided to terminate due to low/slow accrual
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2019-12-12